Lugasi et al. J Nanobiotechnol
(2020) 18:149
Page 15 of 16
results from the national comorbidity survey–adolescent supplement. J
Am Acad Child Adolesc Psychiatry. 2016;55:280–8.
7. Das S, Ng WK, Kanaujia P, Kim S, Tan RBH. Formulation design, prepara‑
tion and physicochemical characterizations of solid lipid nanoparticles
containing a hydrophobic drug: efects of process variables. Colloids Surf
B Biointerfaces. 2011;88:483–9.
8. Sajatovic M, Subramoniam M, Fuller MA. Risperidone in the treatment of
bipolar mania. Neuropsychiatr Dis Treat. 2006;2:127–38.
9. Danel C, Azaroual N, Brunel A, Lannoy D, Vermeersch G, Odou P, et al.
Study of the complexation of risperidone and 9‑hydroxyrisperidone with
cyclodextrin hosts using afnity capillary electrophoresis and 1H NMR
spectroscopy. J Chromatogr A. 2008;1215:185–93.
10. Hannah‑Poquette C, Anderson GW, Flaisher‑Grinberg S, Wang J, Meinerd‑
ing TM, Einat H. Modeling mania: further validation for Black Swiss mice
as model animals. Behav Brain Res. 2011;223:222–6.
11. Cohen LJ. Risperidone. Pharmacother J Hum Pharmacol Drug Ther.
1994;14:253–65.
32. Kile S, Kolitz‑Domb M, Corem‑ Salkmon E, Margel S. Engineered doxo‑
rubicin delivery system using proteinoid‑poly (L‑lactic acid) polymeric
manoparticles of narrow size distribution and high molecular weight for
cancer treatment. Int J Nanotechnol Nanomed. 2017;2:1.
33. Kolitz‑Domb M, Margel S. Recent advances of novel proteinoids and pro‑
teinoid nanoparticles and their applications in biomedicine and industrial
uses. Isr J Chem. 2018;58:1277–85.
34. Shikanov A, Kumar N, Domb AJ. Biodegradable polymers: an update. Isr J
Chem. 2005;45:393–9.
35. Syren RM, Sanjur A, Fox SW. Proteinoid microspheres more stable in hot
than in cold water. BioSystems. 1985;17:275–80.
36. Madhan Kumar AB, Panduranga Rao K. Preparation and characterization
of pH‑sensitive proteinoid microspheres for the oral delivery of metho‑
trexate. Biomaterials. 1998;19:725–32.
37. Urry DW, Channe Gowda D, Peng SQ, Parker TM. Non‑linear hydrophobic‑
induced pKa shifts: implications for efciency of conversion to chemical
energy. Chem Phys Lett. 1995;239:67–74.
12. Rogóż Z. Efect of co‑treatment with mirtazapine and risperidone in
animal models of the positive symptoms of schizophrenia in mice. Phar‑
macol Reports. 2012;64:1567–72.
13. Sun F, Su Z, Sui C, Zhang C, Yuan L, Meng Q, et al. Studies on the acute
toxicity, pharmacokinetics and pharmacodynamics of paliperidone
derivatives—Comparison to paliperidone and risperidone in mice and
rats. Basic Clin Pharmacol Toxicol. 2010;107:656–62.
14. El‑Sherif ZA, El‑Zeany B, El‑Houssini OM. High performance liquid chro‑
matographic and thin layer densitometric methods for the determination
of risperidone in the presence of its degradation products in bulk powder
and in tablets. J Pharm Biomed Anal. 2005;36:975–81.
38. Quirk S. Enhanced catalytic activity from proteinoid microspheres. J
Biomed Mater Res, Part A. 2013;101A:1133–43.
39. Kolitz‑Domb M, Corem‑Salkmon E, Grinberg I, Margel S. Synthesis and
characterization of bioactive conjugated near‑infrared fuorescent
proteinoid‑poly (l‑lactic acid) hollow nanoparticles for optical detection
of colon cancer. Int J Nanomed. 2014;9:5041–53.
40. Kolitz‑Domb M, Grinberg I, Corem‑Salkmon E, Margel S. Engineering of
near infrared fuorescent proteinoid‑poly (l‑lactic acid) particles for in vivo
colon cancer detection. J Nanobiotechnol. 2014;12:30–43.
41. Kulkarni RK, Moore EG, Hegyeli AF, Leonard F. Biodegradable poly(lactic
acid) polymers. J Biomed Mater Res. 1971;5:169–81.
15. Uçok A, Gaebel W. Side efects of atypical antipsychotics: a brief overview.
World Psychiatry. 2008;7:58–62.
16. Lu Y, Chen SC. Micro and nano‑fabrication of biodegradable polymers for
drug delivery. Adv Drug Deliv Rev. 2004;56:1621–33.
17. Leone‑Bay A, McInnes C, Wang NF, DeMorin F, Achan D, Lercara C, et al.
Microsphere formation in a series of derivatized α‑amino acids: proper‑
ties, molecular modeling, and oral delivery of salmon calcitonin. J Med
Chem. 1995;38:4257–62.
42. Bala I, Hariharan S, Kumar MR. PLGA nanoparticles in drug delivery: the
state of the art. Crit Rev Ther Drug Carrier Syst. 2004;21:387–422.
43. Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, Préat V. PLGA‑
based nanoparticles: an overview of biomedical applications. J Control
Release. 2012;161:505–22.
44. Shi M, Lu J, Shoichet MS. Organic nanoscale drug carriers coupled
with ligands for targeted drug delivery in cancer. J Mater Chem.
2009;19:5485–98.
18. Leone‑bay A, Santiago N. N‑acylated alpha‑amino acids as novel oral
delivery agents for proteins. J Med Chem. 1995;38:4263–9.
19. Hans ML, Lowman AM. Biodegradable nanoparticles for drug delivery
and targeting. Curr Opin Solid State Mater Sci. 2002;6:319–27.
20. Karlsson J, Vaughan HJ, Green JJ. Biodegradable polymeric nanopar‑
ticles for therapeutic cancer treatments. Annu Rev Chem Biomol Eng.
2018;9:105–27.
21. George A, Shah PA, Shrivastav PS. Natural biodegradable polymers
based nano‑formulations for drug delivery: a review. Int J Pharm.
2019;561:244–64.
45. Aggarwal P, Hall JB, McLeland CB, Dobrovolskaia MA, McNeil SE.
Nanoparticle interaction with plasma proteins as it relates to particle
biodistribution, biocompatibility and therapeutic efcacy. Adv Drug
Deliv Rev. 2009;61:428–37.
46. Gabizon A, Shmeeda H, Barenholz Y. Pharmacokinetics of PEGylated
liposomal doxorubicin. Clin Pharmacokinet. 2003;42:419–36.
47. Tang BC, Dawson M, Lai SK, Wang YY, Suk JS, Yang M, et al. Biodegrad‑
able polymer nanoparticles that rapidly penetrate the human mucus
barrier. Proc Natl Acad Sci. 2009;106:19268–73.
48. Nance EA, Woodworth GF, Sailor KA, Shih TY, Xu Q, Swaminathan G,
et al. A dense poly(ethylene glycol) coating improves penetration
of large polymeric nanoparticles within brain tissue. Sci Transl Med.
2012;4:149ra119.
22. Naskar S, Kuotsu K, Sharma S. Chitosan‑based nanoparticles as drug
delivery systems: a review on two decades of research. J Drug Target.
2019;27:379–93.
23. Saraiva C, Praça C, Ferreira R, Santos T, Ferreira L, Bernardino L. Nanopar‑
ticle‑mediated brain drug delivery: overcoming blood–brain barrier to
treat neurodegenerative diseases. J Control Release. 2016;235:34–47.
24. Pardridge WM. Blood‑brain barrier and delivery of protein and gene
therapeutics to brain. Front Aging Neurosci. 2020;11:373.
25. Fox SW. How did life begin? Science. 1960;132:200–8.
26. Fox SW. The proteinoid theory of the origin of life and competing ideas.
Am Biol Teach. 1974;36:161–81.
49. Suk JS, Xu Q, Kim N, Hanes J, Ensign LM. PEGylation as a strategy for
improving nanoparticle‑based drug and gene delivery. Adv Drug Deliv
Rev. 2016;99:28–51.
50. Einat H, Shaldubina A, Bersudskey Y, Belmaker RH. Prospects for the
development of animal models for the study of bipolar disorder. In:
Soares JC, Young A, editors. Bipolar disorders: basic mechanisms and
therapeutic implications. New York: Taylor & Francis; 2007.
51. Ene HM, Kara NZ, Einat H. The efects of the atypical antipsychotic
asenapine in a strain‑specifc battery of tests for mania‑like behaviors.
Behav Pharmacol. 2015;26:331–7.
27. Fox SW. Thermal synthesis of amino acids and the origin of life. Geochim
Cosmochim Acta. 1995;59:1213–4.
28. Fox SW, Jungck JR, Nakashima T. From proteinoid microsphere to
contemporary cell: formation of internucleotide and peptide bonds by
proteinoid particles. Orig Life. 1974;5:227–37.
52. Marston HM, Young JW, Martin FDC, Serpa KA, Moore CL, Wong EHF,
et al. Asenapine efects in animal models of psychosis and cognitive
function. Psychopharmacology. 2009;206:699–714.
29. Fox SW, Mccauley RJ, Fukushima T, Windsor CR, Montgome PO. Selec‑
tive action in boundaries of particles of thermal proteinoid. Fed Proc.
1967;26:749.
30. Fox SW, Nakashima T, Przybylski A, Syren RM. The updated experimental
proteinoid model. Int J Quantum Chem. 1982;22:195–204.
31. Kumar AA, Karthick K, Arumugam KP. Properties of biodegradable poly‑
mers and degradation for sustainable development. Int J Chem Eng Appl.
2011;2:164–7.
53. Latt SA, Stetten G, Juergens LA, Willard HF, Scher CD. Recent develop‑
ments in the detection of deoxyribonucleic acid synthesis by 33258
Hoechst fuorescence. J Histochem Cytochem. 1975;23:493–505.
54. Fox SW, Harada K. The thermal copolymerization of amino acids com‑
mon to protein. J Am Chem Soc. 1960;82:3745–51.
55. Kohn J, Langer R. Polymerization reactions involving the side chains of
alpha‑L‑amino acids. J Am Chem Soc. 1987;109:817–20.